Track the Metropolis Healthcare Limited stock price and the full directors' dealings record of the company, a listed issuer based in India. Shares trade on the IN market, under the supervision of SEBI (PIT + SAST). Operating in the Health Care sector, Metropolis Healthcare Limited has published 52 public disclosures. Market capitalisation: €121.4bn. The latest transaction was reported on 30 May 2025 (Sale). Among the most active insiders: Sushil Kanubhai Shah. All data is free.
52
Insider Decl.
n/a
Thresholds
€4m
18 ops.
Buy Volume
€20m
34 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Metropolis Healthcare Limited Buy (bullish), based on 19 analysts. Average price target: ₹615.51.
10Σ signal
Buys €4m€20m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,379 of 28,957 companies
57.0
score / 100
Value
35
Quality
79
FCF yld2.5%
Earn yld1.6%
EV/EBITDA29.6x
ROE13%
Gross mgn78%
Net mgn12%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
336 shares@ ₹2,991.5149100.0% of flowEquity SharesSEBI:2e588da041808c40f2d814a2e9ca149e3f59bbba
25 of 52 declarations
About Metropolis Healthcare Limited
Metropolis Healthcare Limited is a company specializing in medical diagnostic services in India. It offers a wide range of laboratory tests and health services.